1Borehers H, Kirsehner HR, Brehmer B, et al. Permanent 125I-seed brachythcrapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results [ J ]. BJU Int, 2004,94(6) :805-811.
2Portess DI, Baner G, Hill MA, et al. Low-dose irradiation of nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis [ J ]. Cancer Res, 2007,67 (3) : 1246-1253.
3An J, Chervin AS, Nie A, et al. Overcoming the radioresistance of prostate cancer cells with a novel bel-2 inhibitor [ J]. Oneogene, 2007,26(5 ) :652-661.
4Lee W. Daly BD, Di Petrillo TA. et al. Limited resection for nonsmall cell lung cancer: observed local control with implantation of 125I brathytherapy seeds [ J ]. Ann Thorac Surg,2003,75 ( 1 ) :237.
6Patrick CO, Gene HB ,John HS, et al. Brachytherapy for intracranial meningioma using a permanently implanted iodine-125 seed[J].Stereotaet Funct Neurosurg,2002,79( 1 ) :33-43.
7Coopman AM. Pancreatic cancer the bigger picture[ J ]. Surg Clin North Am,2001,81 (3) :557-574.
二级参考文献9
1华积德,主编.肿瘤外科学.北京:人民军医出版社,1995.1703.
2Hilaris BS, Nori D, Beattie EJ, et al. Value of perioperative brachytherapy in themanagement of non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys, 1983,9:1161-1166.
4Yu Y, Anderson LL, Li ZF, et al. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No.64. Med Phys, 1999,26:2054-2076.
5Sommerkamp H, Rupprecht M, Wannenmacher M. Seed loss in interstitial radiotherapy of prostatic carcinoma with 125 I. Int J Radiat Oncol Biol Phys, 1988,14:389-392.
6Stong NN, Stock RG. Permanent seed implantation for localized adnocarcinoma of the prostate. Curr Urol Rep,2002,3:201-206.
4Jiang YL, Meng N, Wang JJ, et al. Percutaneous computed tomography/uhrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent squamous cell cancers of head and neck[J]. Cancer Biol Ther, 2010, 9: 959- 966.
5Sumida I, Koizumi M, Takahashi Y, et al. Verification of air- kerma strength of ^125I seed for permanent prostate implants in Japan[J]. Int J Clin Oncol, 2009, 14:525 - 528.
6Raben A, Mychalczak B, Brennan MF, et al. Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103 Pd brachytherapy[J]. Int J Radiat Oncol Biol Phys, 1996, 35:351 -356.
7WHO handbook for reporting results of cancer treatment [M]. Geneva, Switzerland: World Health Organization, 1979, 48: 22 - 26.
8Kao CH, Hsieh TC, Yu CY, et al. ^18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters[J]. Radiat Oncol, 2010, 5:76.
9LOCK M, CAO JQ, D SOUZA DP, et al. Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip [ J ]. Radiother Oneol,2011,98 ( 3 ) :352 - 356.
10MERRICK GS, SYLVESTER J, GRIMM P, et al. Postimplant rectal dosimetry is not dependent on 103Pd or ^125I seed activity [ J ]. Brachytherapy ,2011,10 ( 1 ) :35 - 43.
